Lipotype Shotgun Lipidomics coupled with the novel superparamagnetic nanoparticles-based organelle purification uncovers lipid composition of plasma membrane and endosomes in storage disorder diseases.
February 6, 2017
An Innovative Medicines Initiative (IMI) Project for Precision Medicine in Diabetic Kidney Disease
with Lipotype as project partner
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year project (total budget 28.9 Million Euro) with the aim to improve prevention and management of Diabetes Kidney Disease (DKD).
December 8, 2016
In the latest issue of the Journal of the American Heart Association, Lipotype and Lund University published a paper in which high-throughput lipidomic screening was successfully applied to reveal molecular lipid profiles in blood serum specific for Diabetes mellitus and myocardial infarction.
November 4, 2016
Berlin/Dresden, 4 November 2016: Kai Simons, founding director of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and managing director of Lipotype GmbH, receives the Robert Koch Medal in Gold for his lifetime achievements, in particular for his characterization of membrane-forming lipids and the development of the lipid raft concept. The Award Ceremony takes place on Friday, November 4th 2016 at the Berlin-Brandenburg Academy of Sciences and Humanities.
September 22, 2016
Lipotype GmbH, a German Max-Planck spin-off company, launched its novel Lipotype Shotgun Skin Lipidomics Technology and offers lipid analysis services for applications such as cosmetic claim support, topical drug development, efficacy testing for dermatological pharmacology and the cosmetic industry.
Professor Kai Simons, Founding Director of the Max-Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG) and Founder/CEO of Lipotype GmbH receives the Robert Koch Medal in Gold for his impressive lifetime achievements, in particular for his characterization of membrane-forming lipids and the development of the Lipid Raft Model.
May 10, 2016
Lipids remained in the shadow of the ongoing “omics” upheaval in biology. But this is now changing. It was never so easy for researchers from universities, research institutes and clinics to try out lipidomics. Lipotype enables researchers to integrate lipidomics in their research. Our lipid analysis start with just 150 Euros per sample, are convenient to order via webshop and deliver publication-ready results.
April 29, 2016
Lipotype collaborated with the groups of Pietro DeCamilli (Yale University School of Medicine) and Ilya Levental (University of Texas) and the results of our lipidomics analysis are now part of their freshly published papers in “Nature Cell Biology” and “Biophysical Journal”. Congratulations!
December 13, 2015
Interview with Professor Kai Simons, CEO and founder of Lipotype regarding the introduction of new service packages and the launch of a webshop in early 2016
October 7, 2015
Press Release, Dresden, 07th October 2015
Lipotype GmbH, a Max-Planck spin-off company and the Nestlé Institute of Health Sciences (NIHS) collaborate to employ the innovative Lipotype Shotgun Lipidomics Technology to analyse lipids in blood for nutritional research. Recently, Lipotype and NIHS jointly published results of the robustness of the Lipotype Technology. Lipotype envisions a future use of its technology in clinical diagnostics screens for establishing reliable lipid diagnostic biomarkers.